Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: Results of the forward (randomized trial to assess efficacy of pufa for the maintenance of sinus rhythm in persistent atrial fibrillation) trial

Journal of the American College of Cardiology

Volumn 61, Issue 4, 2013, Pages 463-468

  MacChia, Alejandro ^a   Grancelli, Hugo ^a   Varini, Sergio ^a   Nul, Daniel ^a   Laffaye, Nicolás ^a   Mariani, Javier ^a   Ferrante, Daniel ^a   Badra, Raúl ^b   Figal, Julio ^c   Ramos, Silvina ^d   Tognoni, Gianni ^e   Doval, Hernán C ^a  

^a Ciudad Autónoma de Buenos Aires   (Argentina)

^b HOSPITAL PRIVADO DE COMUNIDAD   (Argentina)

^c HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^d Clínica Constituyentes   (Argentina)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

atrial fibrillation; polyunsaturated fatty acids; randomized clinical trial

Indexed keywords

OMEGA 3 FATTY ACID; PLACEBO;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLEEDING; CARDIOVERSION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; EMBOLISM; FEMALE; GASTROINTESTINAL INTOLERANCE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SINUS RHYTHM;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FATTY ACIDS, OMEGA-3; FEMALE; HEART FUNCTION TESTS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RECURRENCE; STROKE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84872687915     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.021     Document Type: Article

References (16)

1. D. Bialy, M.H. Lehmann, D.N. Schumacher, R.T. Steinman, M.D. Meissne Hospitalization for arrhythmias in the United States: importance of atrial fibrillation J Am Coll Cardiol 19 1992 41A
2. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
3. J.S. Healey, S.J. Connolly, M.R. Gold ASSERT Investigators Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
4. S. de Denus, C.A. Sanoski, J. Carlsson, G. Opolski, S.A. Spinler Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis Arch Intern Med 165 2005 258 262
5. V. Fuster, L.E. Rydén, D.S. Cannom 2011 ACCF/AHA/HRS focused updated incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
6. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 354 1999 447 455
7. R. Marchioli, F. Barzi, E. Bomba GISSI-Prevenzione Investigators Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
8. A. Jahangiri, W.R. Leifert, G.S. Patten, E.J. McMurchie Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids Mol Cell Biochem 206 2000 33 41
9. L. Bianconi, L. Calò, M. Mennuni n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study Europace 13 2011 174 181
10. P.R. Kowey, J.A. Reiffel, K.A. Ellenbogen, G.V. Naccarelli, C.M. Pratt Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial JAMA 304 2010 2363 2372
11. M. Ozaydn, D. Erdoǧan, S. Tayyar N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study Anadolu Kardiyol Derg 11 2011 305 309
12. A. Erdogan, M. Bayer, D. Kollath OMEGA AF study: polyunsatuated fatty acids (PUFA) for prevention of atrial fibrillation relapse after successful external cardioversion Heart Rhythm 4 2007 S185 S186
13. S. Nodari, M. Triggiani, U. Campia n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study Circulation 124 2011 1100 1106
14. P. Margos, D. Leftheriotis, G. Katsouras, E.G. Livanis, D.T. Kremastinos Influence of n-3 fatty acids intake on secondary prevention after cardioversion of persistent atrial fibrillation to sinus rhythm Europace 9 2007 iii51
15. A. Macchia, S. Varini, H. Grancelli FORomegaARD investigators The rationale and design of the FORomegaARD trial: a randomized, double-blind, placebo-controlled, independent study to test the efficacy of n-3 PUFA for the maintenance of normal sinus rhythm in patients with previous atrial fibrillation Am Heart J 157 2009 423 427
16. B.N. Singh, S.N. Singh, D.J. Reda Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators Amiodarone versus sotalol for atrial fibrillation N Engl J Med 352 2005 1861 1872